Hadir Karam | Antimicrobial | Innovative Research Award

Posted on by International Research Awards on Infectious Diseases

Innovative Research Award

Hadir Karam – Misr University for Science and Technology – Egypt

Hadir Karam
Affiliation Misr University for Science and Technology
Country Egypt
Google Scholar ID yfAiXzAAAAAJ
Documents 1
Citations 5
h-index 1
Subject Area Antimicrobial
Event International Research Awards on Infectious Diseases
ORCID 0000-0003-4753-7529

The Innovative Research Award recognizes research contributions that demonstrate originality, scientific relevance, and potential value to their respective fields. This article presents a structured overview of Hadir Karam’s supplied academic profile, institutional affiliation, reported research metrics, and potential relevance to antimicrobial research within the broader field of infectious diseases. The information is organized for academic reference and should be interpreted in accordance with the limitations of the available profile data.

Abstract

Hadir Karam is identified in the supplied profile information as being affiliated with Misr University for Science and Technology in Egypt, with antimicrobial research listed as the principal subject area. The profile data provided for this article report one document, five citations, and an h-index of one. These indicators offer a limited quantitative snapshot of the research record but do not independently establish the originality, methodological quality, or practical significance of an individual contribution. This article outlines the relevance of antimicrobial research to infectious disease research and describes considerations for evaluating potential suitability for an Innovative Research Award. The information should be verified against the researcher’s current bibliographic records and the award organizer’s official criteria before being used for formal recognition. [1] [2]

Keywords

Hadir Karam, Innovative Research Award, antimicrobial research, infectious diseases, antimicrobial agents, scientific innovation, research evaluation, bibliometrics, scholarly publications, Egypt, Misr University for Science and Technology.

Introduction

Antimicrobial research is an important component of biomedical science because it addresses the prevention, detection, and treatment of infections caused by bacteria, fungi, viruses, and other microorganisms. Research in this area can involve the investigation of antimicrobial compounds, mechanisms of resistance, therapeutic effectiveness, pathogen biology, and strategies for improving the responsible use of antimicrobial agents. Antimicrobial resistance is recognized internationally as a significant public health challenge requiring coordinated research, surveillance, and intervention. [3]

Research Profile

The supplied profile identifies Hadir Karam as a researcher affiliated with Misr University for Science and Technology, Egypt. Antimicrobial research is the stated subject area. An ORCID identifier has also been provided, enabling access to a persistent researcher identifier that can assist with distinguishing scholarly records and connecting research outputs with their author. [2]

Research Contributions

Antimicrobial research encompasses a range of scientific questions relevant to infectious disease management. Potential contributions in this subject area may include the identification of candidate antimicrobial compounds, characterization of microbial susceptibility, investigation of resistance mechanisms, evaluation of treatment approaches, and development of improved laboratory methods. The significance of any particular contribution depends on the research question, supporting evidence, and relevance to the field..[3]

Publications

The supplied bibliometric information lists one document associated with the researcher. However, a publication title, author list, journal name, publication year, and DOI were not included in the source information provided for this article. It is therefore not possible to produce a verified publication bibliography or to assign a particular scientific finding to the reported document without further records.[3]

Research Impact

Research impact can be examined through complementary quantitative and qualitative indicators. Quantitative indicators summarize publication and citation patterns, whereas qualitative assessment considers the scientific content, reliability, originality, and potential significance of the work. Neither type of evidence should be treated as a complete measure of research quality in isolation. [2]

Award Suitability

The Innovative Research Award is associated in the supplied information with the International Research Awards on Infectious Diseases. Given the stated subject area of antimicrobial research, the researcher’s profile may be relevant to an award program concerned with infectious disease research. Final eligibility and suitability, however, depend on the organizer’s published criteria and an assessment of the actual research submission.[1]

Conclusion

Hadir Karam is identified in the supplied information as being affiliated with Misr University for Science and Technology in Egypt, with antimicrobial research listed as the subject area. The profile metrics provided for this article comprise one document, five citations, and an h-index of one. These figures offer a limited bibliometric overview and should be interpreted alongside the underlying research outputs.[2]

References

  1. Google Scholar. (n.d.). Google Scholar profile of Hadir Karam. Google Scholar.
    https://scholar.google.com/citations?user=yfAiXzAAAAAJ&hl=en
  2. Ahmed, H. K., Molham, F., El-Gendy, A. O., & Ahmed, M. A. E.-S. (n.d.). Coexistence of carbapenem resistance and hypervirulence in clinical Klebsiella pneumoniae isolates: A molecular and phenotypic analysis.
    https://link.springer.com/article/10.1186/s12879-025-11585-z
  3. ORCID. (n.d.). ORCID profile of Hadir Karam. ORCID Registry.
    https://orcid.org/0000-0003-4753-7529

Guang-Yu Pan | Antimicrobial | Best Researcher Award

Posted on by International Research Awards on Infectious Diseases

Guang-Yu Pan | Antimicrobial | Best Researcher Award

Dr. Guang-Yu Pan, Guilin Medical University, China.

Dr. Guang-Yu Pan is an Associate Professor of Biomedical Engineering at Guilin Medical University, Guilin, China. He earned his Ph.D. from Southeast University in 2018 and joined Guilin Medical University the same year. Promoted to Associate Professor in 2022, Dr. Pan specializes in antimicrobial materials, hemostatic agents, and tissue regeneration materials, addressing critical challenges in healthcare. He has published seven first-author or corresponding-author papers in prestigious international journals, including ACS Applied Nano Materials, Nanoscale, and International Journal of Biological Macromolecules. Dr. Pan’s innovative research continues to advance the frontiers of biomedical engineering.

Professional Profiles

Scopus Profile

Orcid  Profile

📚Education

Dr. Pan completed his Ph.D. in Biomedical Engineering at Southeast University, Nanjing, China, in 2018, focusing on advanced biomaterials for medical applications. He earned his M.Sc. in Biomedical Engineering from the same institution in 2015, specializing in material characterization and biomaterial innovations. He began his academic journey at Guilin Medical University, where he completed his B.Sc. in Biomedical Engineering in 2012, focusing on the fundamentals of medical materials and engineering principles.

💼Experience

Dr. Pan began his professional career at Guilin Medical University in 2018 as a Lecturer in Biomedical Engineering. In 2022, he was promoted to Associate Professor, recognizing his exceptional contributions to research and teaching. His professional experience combines academia, research innovation, and leadership in advancing biomedical solutions.As a dedicated educator, Dr. Pan teaches undergraduate and postgraduate courses in Biomedical Engineering. His teaching focuses on biomaterials, tissue engineering, and the medical applications of material science. He integrates his research findings into the curriculum, providing students with a cutting-edge understanding of the field.

🔬Research Interest

Dr. Pan’s research centers on antimicrobial materials, addressing infections and improving healthcare outcomes. He also focuses on the development of hemostatic agents for effective wound care and the design of innovative biomaterials to support tissue regeneration. His work contributes significantly to the advancement of medical science and technology.

 

👩‍🏫Technical Skills

Dr. Pan is skilled in developing and synthesizing antimicrobial materials and hemostatic agents with applications in wound healing and infection control. He is proficient in designing biomaterials for tissue regeneration and employing advanced techniques for material characterization and biomedical innovations. His expertise bridges material science and healthcare applications.

📑Top Note Publications

Title: A thermoresponsive metabolic nanomodulator for achieving photochemotherapy-sensitized cancer immunotherapy

Authors: Wu, S.-Y.; Zhu, X.-Y.; Zhang, X.; … Xu, B.; Wu, F.-G.
Publication Year: 2024
Citations: 1

Title: Research progress on sensitization mechanism of gemcitabine combined with other drugs in treatment of pancreatic cancer | 吉西他滨联合用药治疗胰腺癌增敏作用机制研究进展

Authors: Liu, M.; Deng, J.; Lei, D.; … Tang, S.; Xie, W.
Publication Year: 2024
Citations: 0

Title: Devastating the Supply Wagons: Multifaceted Liposomes Capable of Exhausting Tumor to Death via Triple Energy Depletion

Authors: Wang, T.-Y.; Zhu, X.-Y.; Jia, H.-R.; … Pan, G.-Y.; Wu, F.-G.
Publication Year: 2024
Citations: 1

Title: Turning dextran into antibacterial fibers: Quaternary ammonium salt for antibacterial treatment and wound healing

Authors: Pan, G.; Wang, Q.; Ding, H.; … Gao, S.; Wang, L.
Publication Year: 2024
Citations: 2

Title: Antioxidant and antibacterial hydrogel formed by protocatechualdehyde–ferric iron complex and aminopolysaccharide for infected wound healing

Authors: Deng, J.; Gao, S.; Liu, M.; Xie, W.; Pan, G.-Y.
Publication Year: 2024
Citations: 1

Introduction of Antibiotic

Posted on by International Research Awards on Infectious Diseases

Introduction of Antibiotic

Antibiotics are powerful medications used to treat infections caused by bacteria. They work by killing bacteria or inhibiting their growth, helping to cure infections that would otherwise become severe or life-threatening. Antibiotics have revolutionized modern medicine since their discovery, drastically reducing mortality from bacterial infections. However, the misuse and overuse of antibiotics have led to increasing levels of antibiotic resistance, posing a significant threat to global health.

  • Types of Antibiotics:
  1. Broad-spectrum Antibiotics:
    These antibiotics work against a wide variety of bacteria, both Gram-positive and Gram-negative. Examples include:

    • Amoxicillin
    • Tetracycline
    • Ciprofloxacin
  2. Narrow-spectrum Antibiotics:
    These antibiotics target specific types of bacteria. Examples include:

    • Penicillin G (used mainly against Gram-positive bacteria)
    • Vancomycin (used against resistant Gram-positive bacteria)
  3. Bactericidal Antibiotics:
    These kill bacteria by attacking their cell walls or vital cellular functions. Examples include:

    • Penicillin
    • Cephalosporins
    • Aminoglycosides
  4. Bacteriostatic Antibiotics:
    These inhibit bacterial growth by interfering with bacterial protein production or DNA replication. Examples include:

    • Tetracycline
    • Sulfonamides
    • Chloramphenicol
  • How Antibiotics Work:
  • Antibiotics target key processes in bacteria that are essential for their survival and replication. These include:
  • Cell wall synthesis inhibition: Prevents bacteria from forming cell walls, leading to cell death (e.g., Penicillin).
  • Protein synthesis inhibition: Disrupts bacterial ribosomes, which produce proteins essential for cell function (e.g., Tetracycline).
  • DNA replication inhibition: Prevents bacterial DNA replication, halting cell division (e.g., Quinolones).
  • Cell membrane disruption: Damages bacterial cell membranes, leading to cell death (e.g., Polymyxins).

    Examples of Antibiotic-Resistant Bacteria:

    1. Methicillin-resistant Staphylococcus aureus (MRSA): Resistant to many antibiotics, causing serious skin infections.
    2. Vancomycin-resistant Enterococci (VRE): Often found in hospital-acquired infections.
    3. Carbapenem-resistant Enterobacteriaceae (CRE): Highly resistant to most antibiotics and often fatal.
    4. Multidrug-resistant Mycobacterium tuberculosis (MDR-TB): Resistant to the two most powerful anti-TB drugs, requiring complex and prolonged treatment.
  • Understanding and managing animal infectious diseases is crucial for animal health, public health, and maintaining food security.

 

Introduction of Animal Infectious Diseases
Introduction of Animal infectious diseases Animal infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites that can affect a wide range of animal species.